This article was originally published in The Rose Sheet
Executive SummaryFragrance supplier does not anticipate $20 mil. court decision "to have a material adverse effect" on its financial results, operating results or liquidity, IFF states after Missouri circuit court ruled against the company March 15. Court awarded $20 mil. in compensatory damages to a former employee of one of IFF's customers, who claimed he sustained respiratory damage in the workplace from the facility's use of a butter flavor supplied by IFF. Company plans to appeal the decision, stating the verdict is "not supported by the evidence or the law and should therefore be reversed." Plaintiff, however, is one of a number of employees who worked at the facility owned and operated by Gilster-Mary Lee Corporation in Jasper, Miss. that are suing IFF. Firm states the majority of plaintiffs claim to have sustained lesser respiratory injuries than the awarded plaintiff...
You may also be interested in...
The AAM has cited multiple reasons for the failure of Medicare Part D to get new generics to its patients, forcing up their costs. The association has offered a list of suggestions to “ensure that first generics are covered at launch, with lower cost-sharing.”
The US FDA is updating its labeling guidance on laparoscopic power morcellation to reflect new evidence showing the treatment may pose a higher cancer risk in older women, as well as to add discussion of containment systems.
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.